Cargando…
The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is one of the leading causes of vision loss worldwide. Although screening and early treatment guidelines for DR have significantly reduced the disease burden, restrictions related to the COVID-19 pandemic have changed real-world practice patterns in the m...
Autores principales: | Ahmed, Ishrat, Liu, T. Y. Alvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425316/ https://www.ncbi.nlm.nih.gov/pubmed/34495377 http://dx.doi.org/10.1007/s11892-021-01411-6 |
Ejemplares similares
-
Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
por: Everett, Lesley A., et al.
Publicado: (2021) -
Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy
por: Sachdeva, Mira M.
Publicado: (2021) -
Animal Models of Diabetic Retinopathy
por: Olivares, Ana Maria, et al.
Publicado: (2017) -
Screening Intervals for Diabetic Retinopathy and Implications for Care
por: Scanlon, Peter H.
Publicado: (2017) -
Painful and Painless Diabetic Neuropathies: What Is the Difference?
por: Shillo, Pallai, et al.
Publicado: (2019)